DRISCOLL FREDERICK W
Insider CIK 1129890 · NVAX VP, CFO & Treasurer · LITS Director · CLRB Director · NK Director · FLXN Chief Financial Officer · CUE Director · RCOR Chief Financial Officer · OXGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LITS Lite Strategy, Inc. | A Award deriv | 2026-10-22 | 2026-10-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2026-07-07 | 2026-07-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LITS Lite Strategy, Inc. | A Award deriv | 2025-11-14 | 2025-11-18 | 55,000 | — | $0 | 55,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2025-07-15 | 2025-07-17 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2025-02-14 | 2025-02-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2024-01-02 | 2024-01-04 | 24,400 | — | $0 | 24,400 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2023-09-29 | 2023-10-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2023-06-28 | 2023-06-28 | 25,000 | — | $0 | 47,650 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2022-07-05 | 2022-07-07 | 88 | — | $0 | 87,500 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2022-06-24 | 2022-08-01 | 7,800 | — | $0 | 7,800 | SEC↗ |
| RCOR Renovacor, Inc. | A Award deriv | 2022-03-28 | 2022-03-28 | 155,325 | — | $0 | 155,325 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 168,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 30,680 | $8.50 | $260.8K | 0 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | P Buy | 2021-09-03 | 2021-09-07 | 19,417 | $1.04 | $20.2K | 19,417 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2021-07-01 | 2021-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2021-06-30 | 2021-07-02 | 78,000 | — | $0 | 78,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-06-01 | 2021-06-03 | 168,000 | — | $0 | 168,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-06-01 | 2021-06-03 | 28,000 | — | $0 | 30,680 | SEC↗ |
| MEIP MEI Pharma, Inc. | S Sale | 2021-02-23 | 2021-02-24 | 25,000 | $4.03 | $100.8K | 37,500 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 10,000 | $9.98 | $99.8K | 114,535 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 50,000 | $10.22 | $511.0K | 124,535 | SEC↗ |
| NK NantKwest, Inc. | S Sale | 2020-08-11 | 2020-08-13 | 5,300 | $10.77 | $57.1K | 109,235 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2020-07-02 | 2020-07-07 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2020-06-24 | 2020-06-25 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2020-06-10 | 2020-06-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2020-01-02 | 2020-01-06 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | P Buy | 2019-12-19 | 2019-12-20 | 62,500 | $1.60 | $100.0K | 62,500 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2019-06-13 | 2019-06-14 | 6,500 | — | $0 | 6,500 | SEC↗ |
| NK NantKwest, Inc. | A Award | 2019-06-06 | 2019-06-07 | 92,592 | — | $0 | 174,535 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2019-01-02 | 2019-01-03 | 8,000 | — | $0 | 8,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2018-10-12 | 2018-10-15 | 13,000 | — | $0 | 13,000 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2018-07-12 | 2018-07-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CUE Cue Biopharma, Inc. | A Award deriv | 2018-06-26 | 2018-06-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NK NantKwest, Inc. | A Award | 2018-06-07 | 2018-06-11 | 27,322 | — | $0 | 81,943 | SEC↗ |
| MEIP MEI Pharma, Inc. | A Award deriv | 2018-02-22 | 2018-02-26 | 33,333 | — | $0 | 33,333 | SEC↗ |
| NK NantKwest, Inc. | A Award | 2017-09-18 | 2017-09-20 | 54,621 | — | $0 | 54,621 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2017-05-31 | 2017-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise deriv | 2017-03-23 | 2017-03-24 | 3,000 | — | $0 | 102,300 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2017-03-23 | 2017-03-24 | 3,000 | $23.00 | $69.0K | 7,777 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise | 2017-03-23 | 2017-03-24 | 3,000 | $7.89 | $23.7K | 10,777 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise deriv | 2017-02-28 | 2017-03-02 | 30,000 | — | $0 | 105,300 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2017-02-28 | 2017-03-02 | 600 | $20.42 | $12.3K | 7,777 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2017-02-28 | 2017-03-02 | 32,834 | $19.96 | $655.4K | 8,377 | SEC↗ |
| FLXN Flexion Therapeutics Inc | M Exercise | 2017-02-28 | 2017-03-02 | 30,000 | $7.89 | $236.7K | 41,211 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-12-20 | 2016-12-22 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | J Other | 2016-12-20 | 2016-12-27 | 1,134 | $9.01 | $10.2K | 10,531 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2016-06-01 | 2016-06-03 | 91,564 | — | $0 | 91,564 | SEC↗ |
| FLXN Flexion Therapeutics Inc | J Other | 2016-05-20 | 2016-05-24 | 963 | $8.92 | $8.6K | 9,397 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-05-17 | 2016-05-18 | 2,500 | $9.87 | $24.7K | 8,434 | SEC↗ |
| FLXN Flexion Therapeutics Inc | P Buy | 2016-05-16 | 2016-05-17 | 2,500 | $9.19 | $23.0K | 5,934 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-01-04 | 2016-01-06 | 25,650 | — | $0 | 25,650 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2016-01-04 | 2016-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2015-05-28 | 2015-05-29 | 77,996 | — | $0 | 77,996 | SEC↗ |
| FLXN Flexion Therapeutics Inc | J Other | 2015-05-20 | 2015-05-27 | 1,311 | $11.91 | $15.6K | 2,754 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2015-01-21 | 2015-01-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | J Other | 2014-11-20 | 2014-11-26 | 1,443 | $11.91 | $17.2K | 1,443 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2014-07-02 | 2014-07-07 | 7,920 | — | $0 | 7,920 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2014-03-03 | 2014-03-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2014-01-02 | 2014-01-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OXGN OXIGENE INC | A Award deriv | 2014-01-02 | 2014-01-06 | 7,310 | — | $0 | 7,310 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2013-03-02 | 2013-03-06 | 150,000 | $1.83 | $274.5K | 730,000 | SEC↗ |
| NVAX NOVAVAX INC | A Award deriv | 2012-03-01 | 2012-03-08 | 150,000 | $1.28 | $192.0K | 580,000 | SEC↗ |